MV Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.5K | Buy |
63
+3
| +5% | +$978 | ﹤0.01% | 440 |
|
|
2025
Q1 | $16.2K | Buy |
60
+10
| +20% | +$2.7K | ﹤0.01% | 457 |
|
|
2024
Q4 | $11.8K | Buy |
50
+10
| +25% | +$2.35K | ﹤0.01% | 499 |
|
|
2024
Q3 | $11K | Buy |
40
+14
| +54% | +$3.85K | ﹤0.01% | 515 |
|
|
2024
Q2 | $6.32K | Buy |
26
+21
| +420% | +$5.1K | ﹤0.01% | 578 |
|
|
2024
Q1 | $748 | Buy |
5
+2
| +67% | +$299 | ﹤0.01% | 695 |
|
|
2023
Q4 | $575 | Buy |
+3
| New | +$575 | ﹤0.01% | 678 |
|